Medicare Enrolled
Dr. Syed Ahmed, M.D.
Medical Oncology · Sebring, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ahmed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ahmed? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ahmed
Dr. Syed Ahmed is a medical oncology in Sebring, FL, with 20 years in practice. Based on federal Medicare data, Dr. Ahmed performed 182,985 Medicare services across 4,956 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ahmed received a total of $33,388 from 106 pharmaceutical and/or device companies across 1619 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ahmed is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 14% volume in FL$ $33,388 industry payments
Medicare Practice Summary
Medicare Utilization ↗182,985
Medicare services
Top 14% in FL for medical oncology
4,956
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,149 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 50,490 | $0 | $4 |
| Iron sucrose injection (Venofer) | 38,300 | $0 | $5 |
| Filgrastim injection (Zarxio) for white blood cells | 15,060 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 13,780 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 13,320 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 9,991 | $6 | $23 |
| Paclitaxel chemotherapy injection | 8,333 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 7,000 | $43 | $137 |
| Immune globulin infusion (Gammagard) | 4,624 | $36 | $108 |
| Inclisiran injection (Leqvio) for cholesterol | 3,692 | $9 | $49 |
| Dexamethasone injection (steroid) | 2,816 | $0 | $3 |
| Complete blood count (CBC) with differential | 2,480 | $8 | $29 |
| Blood draw (venipuncture) | 2,383 | $8 | $9 |
| Office visit, established patient (30-39 min) | 1,651 | $95 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,440 | $1 | $28 |
| Drug injection, under skin or into muscle | 1,209 | $10 | $69 |
| Injection of additional new drug or substance into vein | 755 | $12 | $61 |
| Anti-nausea injection (ondansetron/Zofran) | 556 | $0 | $9 |
| Injection, leucovorin calcium, per 50 mg | 553 | $3 | $12 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 435 | $1 | $6 |
| Administration of chemotherapy into vein, 1 hour or less | 411 | $97 | $378 |
| Injection, fluorouracil, 500 mg | 387 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 348 | $48 | $189 |
| Injection, carboplatin, 50 mg | 289 | $2 | $41 |
| Office visit, established patient (20-29 min) | 226 | $65 | $239 |
| Hospital follow-up visit, moderate complexity | 223 | $62 | $197 |
| Injection, diphenhydramine hcl, up to 50 mg | 168 | $1 | $3 |
| Injection of drug or substance into vein | 157 | $28 | $156 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 137 | $16 | $56 |
| Administration of chemotherapy into vein, each additional hour | 136 | $22 | $79 |
| New patient office visit, complex (60-74 min) | 130 | $160 | $585 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 123 | $132 | $562 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 112 | $21 | $84 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 110 | $16 | $59 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 104 | $54 | $206 |
| Initial hospital admission, high complexity | 95 | $137 | $556 |
| Administration of additional new drug or substance into vein, 1 hour or less | 93 | $49 | $178 |
| Infusion, normal saline solution , 1000 cc | 93 | $2 | $7 |
| Injection, zoledronic acid, 1 mg | 92 | $7 | $69 |
| Infusion into a vein for hydration, each additional hour | 82 | $9 | $42 |
| Red blood count automated, with additional calculations | 68 | $5 | $20 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 61 | $3 | $11 |
| Injection, magnesium sulfate, per 500 mg | 58 | $1 | $2 |
| Administration of additional new drug or substance into vein using push technique | 55 | $42 | $170 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 50 | $24 | $89 |
| Infusion into a vein for hydration, 31-60 minutes | 46 | $24 | $156 |
| Drawing of blood for a medical problem | 45 | $67 | $277 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 34 | $120 | $637 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $62 | $192 |
| Red blood count, automated test | 26 | $4 | $10 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 26 | $1 | $7 |
| Office visit, established patient, complex (40-54 min) | 25 | $140 | $474 |
| New patient office visit (45-59 min) | 23 | $125 | $453 |
| Automated urinalysis | 21 | $2 | $8 |
| Hospital follow-up visit, high complexity | 19 | $94 | $285 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 17 | $124 | $467 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
30.6% high complexity
65.1% medium
4.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$33,388
Total received (2018-2024)
Avg $4,770/year across 7 years
Top 17% in FL for medical oncology
106
Companies
1,619
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$31,283 (93.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,105 (6.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$6,885
2023$6,413
2022$4,968
2021$4,350
2020$3,448
2019$3,444
2018$3,880
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,673
Novartis Pharmaceuticals Corporation
$2,292
Janssen Biotech, Inc.
$2,247
E.R. Squibb & Sons, L.L.C.
$2,009
Astellas Pharma US Inc
$1,498
PFIZER INC.
$1,437
Amgen Inc.
$1,373
Incyte Corporation
$1,244
Celgene Corporation
$1,047
Genentech USA, Inc.
$1,039
Merck Sharp & Dohme LLC
$936
GENZYME CORPORATION
$929
Lilly USA, LLC
$903
Merck Sharp & Dohme Corporation
$824
Seagen Inc.
$612
Daiichi Sankyo Inc.
$526
Rigel Pharmaceuticals, Inc.
$518
GlaxoSmithKline, LLC.
$472
Bayer HealthCare Pharmaceuticals Inc.
$472
Bayer Healthcare Pharmaceuticals Inc.
$462
Takeda Pharmaceuticals U.S.A., Inc.
$451
Eisai Inc.
$443
Alnylam Pharmaceuticals Inc.
$379
SOBI, INC
$367
Ipsen Biopharmaceuticals, Inc
$333
ARRAY BIOPHARMA INC
$318
Gilead Sciences, Inc.
$310
Alexion Pharmaceuticals, Inc.
$305
Myriad Genetic Laboratories, Inc.
$277
Regeneron Healthcare Solutions, Inc.
$275
Pharmacyclics LLC, An AbbVie Company
$261
ABBVIE INC.
$257
Exelixis Inc.
$252
Seattle Genetics, Inc.
$243
EISAI INC.
$231
AbbVie, Inc.
$206
Stemline Therapeutics Inc.
$180
BeiGene USA, Inc.
$178
PharmaEssentia USA Corporation
$172
Boehringer Ingelheim Pharmaceuticals, Inc.
$171
Pharmacosmos Therapeutics Inc.
$171
Dova Pharmaceuticals
$166
Coherus Biosciences Inc.
$166
Jazz Pharmaceuticals Inc.
$160
TerSera Therapeutics LLC
$146
Foundation Medicine, Inc.
$139
JAZZ PHARMACEUTICALS INC.
$138
PUMA BIOTECHNOLOGY, INC.
$138
MorphoSys, US Inc.
$138
EMD Serono, Inc.
$134
TESARO, Inc.
$133
AbbVie Inc.
$129
G1 Therapeutics, Inc.
$123
Pharmacyclics LLC, an AbbVie Company
$116
Sobi, Inc
$115
Kyowa Kirin, Inc.
$112
Karyopharm Therapeutics Inc.
$112
Deciphera Pharmaceuticals Inc.
$97
Clovis Oncology, Inc.
$93
Janssen Products, LP
$85
Secura Bio, Inc.
$81
ImmunoGen, Inc.
$79
CTI BioPharma Corp.
$79
Dendreon Pharmaceuticals LLC
$76
Kite Pharma, Inc.
$75
Taiho Oncology, Inc.
$73
Adaptive Biotechnologies Corporation
$73
Mirati Therapeutics, Inc.
$58
EUSA Pharma (US) LLC
$56
AMAG Pharmaceuticals, Inc.
$54
Agios Pharmaceuticals, Inc.
$46
Myovant Sciences Inc.
$46
SERVIER PHARMACEUTICALS LLC
$46
AVEO Pharmaceuticals, Inc.
$43
Sysmex Inostics Inc
$43
Global Blood Therapeutics, Inc.
$43
GE HEALTHCARE
$39
Janssen Pharmaceuticals, Inc
$38
SANOFI-AVENTIS U.S. LLC
$34
Spectrum Pharmaceuticals Inc.
$34
RECORDATI_RARE_DISEASES_INC.
$31
Sumitomo Pharma America, Inc.
$31
Puma Biotechnology, Inc.
$29
Acceleron Pharma, Inc.
$29
Helsinn Therapeutics (U.S.), Inc.
$29
Tempus AI, Inc
$29
Blueprint Medicines Corporation
$27
Aveo Pharmaceuticals, Inc.
$26
SECURA BIO, INC.
$25
Acrotech Biopharma Inc.
$24
Servier Pharmaceuticals LLC
$23
GE HealthCare
$22
Apellis Pharmaceuticals, Inc.
$18
Tolmar, Inc.
$18
Immunocore Limited
$18
Genmab U.S., Inc.
$18
TG Therapeutics, Inc.
$18
Heron Therapeutics, Inc.
$18
TAIHO ONCOLOGY, INC.
$17
TOLMAR Pharmaceuticals, Inc.
$16
Epizyme, Inc.
$16
Acrotech Biopharma LLC
$15
INSYS Therapeutics Inc
$12
Veracyte, Inc.
$12
Medtronic Vascular, Inc.
$11
NOVARTIS PHARMACEUTICALS CORPORATION
$6
Top 3 companies account for 21.6% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AMVUTTRA · ANDEXXA · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRACAnalysis · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EVENITY · Elahere · Empaveli · Enhertu · Epkinly · FARESTON · FARYDAK · FASENRA · FEMARA · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · IMDELLTRA (AMG 757) · IMFINZI · INCRELEX · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · Micra · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSTATE CANCER - DISEASE · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYLVANT · SYNAGIS · SYNDROS · Stivarga · Sylvant · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VONVENDI · VOTRIENT · VYXEOS · Venclexta · Vonjo · Vyloy · XALKORI · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zoladex · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $18 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
2
Per 100K population
1.9
County median income
$55,581
Nearest hospital
HCA FLORIDA HIGHLANDS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ahmed is a mixed practice specialist, with above-average Medicare volume (top 14% in FL), and high industry engagement (low-engagement, top 17%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ahmed experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Ahmed performed 50,490 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ahmed receive payments from pharmaceutical companies?
Yes. Dr. Ahmed received a total of $33,388 from 106 companies across 1,619 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ahmed's costs compare to other medical oncologys in Sebring?
Dr. Ahmed's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ahmed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Sebring
Browse medical oncologys in Sebring ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology